KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Equity Ratio (2016 - 2025)

Ionis Pharmaceuticals has reported Equity Ratio over the past 17 years, most recently at 0.14 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.14 for Q4 2025, down 29.14% from a year ago — trailing twelve months through Dec 2025 was 0.14 (down 29.14% YoY), and the annual figure for FY2025 was 0.14, down 29.14%.
  • Equity Ratio for Q4 2025 was 0.14 at Ionis Pharmaceuticals, down from 0.2 in the prior quarter.
  • Over the last five years, Equity Ratio for IONS hit a ceiling of 0.3 in Q1 2021 and a floor of 0.1 in Q2 2024.
  • Median Equity Ratio over the past 5 years was 0.21 (2025), compared with a mean of 0.2.
  • Biggest five-year swings in Equity Ratio: tumbled 56.19% in 2023 and later skyrocketed 115.97% in 2025.
  • Ionis Pharmaceuticals' Equity Ratio stood at 0.3 in 2021, then fell by 23.49% to 0.23 in 2022, then tumbled by 42.8% to 0.13 in 2023, then surged by 51.46% to 0.2 in 2024, then dropped by 29.14% to 0.14 in 2025.
  • The last three reported values for Equity Ratio were 0.14 (Q4 2025), 0.2 (Q3 2025), and 0.21 (Q2 2025) per Business Quant data.